Ubs Asset Management Americas Inc Novavax Inc Transaction History
Ubs Asset Management Americas Inc
- $345 Billion
- Q2 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Novavax Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 254,780 shares of NVAX stock, worth $3.14 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
254,780
Previous 86,065
196.03%
Holding current value
$3.14 Million
Previous $411,000
684.67%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding NVAX
# of Institutions
284Shares Held
83.2MCall Options Held
5.43MPut Options Held
9M-
Vanguard Group Inc Valley Forge, PA14.1MShares$173 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$146 Million0.0% of portfolio
-
Shah Capital Management9.66MShares$119 Million41.87% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY6.32MShares$77.9 Million0.08% of portfolio
-
State Street Corp Boston, MA6.07MShares$74.7 Million0.0% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $964M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...